This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rochester Medical Corporation's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Rochester Medical Corporation (ROCM)

Q2 2012 Earnings Call

April 24, 2012 4:30 pm ET

Executives

Anthony J. Conway – Chairman of the Board, Chief Executive Officer and President

David A. Jonas – Director, Chief Financial Officer, Treasurer and Secretary

Analysts

Tyson Bauer – Kansas City Capital Associates

Elizabeth Lilly – Gabelli Investors

Michael Boulgaris – Boulgaris Investments

Presentation

Operator

Good afternoon, ladies and gentlemen, and welcome to the Second Quarter 2012 Rochester Medical Corporation Earnings Conference Call. My name is Chris and I will be your moderator for today. Presently all participants are in a listen-only mode. Later, we will facilitate a question-and-answer session. (Operator Instructions) As a reminder, this conference is being recorded for replay purposes.

And at this time, I would now like to turn the conference over to your presenter for today, Mr. Jim Conway, President and CEO. Sir, you may proceed.

Anthony J. Conway

Thank you for joining Rochester Medical’s second quarter conference call. I’m Jim Conway, the company’s President and CEO. And with me is David Jonas, Rochester Medical’s Chief Financial Officer. First, I will provide a brief high level review of our second quarter, and Dave will then provide you with more details on our financial results. And then, I will give a quick update on a few items and summarize and then we’ll take your questions.

Before starting, let me remind you that we will be making some forward-looking statements today, and I would refer you to the Safe Harbor statement found in today’s press release and also to the risk factors section in the company’s annual report on Form 10-K for the year ended September the 30, 2011. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs